This summer, the U.S. Preventive Service Task Force released its draft recommendation for preventive screenings that have the potential to help current and former smokers at high risk for lung cancer, proposing that clinicians provide low-dose computerized tomography (“CT scans”) to eligible patients. This announcement marks a significant shift in how lung cancer screenings are integrated into the nation’s preventive health system.

On September 10, 2013, Legacy, along with Lung Cancer Alliance, both long and vocal proponents of such screenings, hosted a round-table discussion as part of the Kenneth E. Warner Series Lecture aimed at de-mystifying lung cancer screening. Participants can apply for CME/CEU credit here*.


  • Provide the national public health community with accurate information about the efficacy and significance of lung cancer screenings – including how to educate members of the public of their risks and ensure that they have information about where to be screened responsibly.
  • Discuss next steps for national public health and public policy decision makers, including tobacco control and community level advocates who are at the frontline in efforts to stem the deadly tide of tobacco. 
  • Identify areas of common ground where the tobacco control community and proponents of lung cancer screening can work together to sharply reduce tobacco related deaths from lung cancer.
  • This video features Legacy’s Immediate Past President and CEO, Cheryl Healton, Dr.PH.

    Demystifying Lung Cancer Screening: The Path from U.S. Preventive Service Task Force Recommendation to Implementation

    View Related Multimedia
    Share This

View the webcast here.


Cheryl Healton

Dr. Cheryl Healton

Immediate Past President and CEO, Legacy


Georges Benjamin, MD, Executive Director, APHA

Fred Grannis, MD, Clinical Professor of Thoracic Surgery, City of Hope National Medical Center in Duarte, CA

Bruce S. Pyenson, Principal and Consulting Actuary, Milliman

Andrea McKee, MD, Chair, Lahey Clinic Radiation Oncology

Laurie Fenton Ambrose, President and CEO, Lung Cancer Alliance

Marcus Plescia, MD, MPH, Director of the Division of Cancer Prevention and Control, U.S. Centers for Disease Control and Prevention

*Accreditation:The University of California, San Francisco (UCSF) School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians and allied health professionals.

This is a jointly sponsored event with the Smoking Cessation Leadership Center. UCSF designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Participants who join theLIVE session, onSept. 10, 2013, are eligible to earn up to 1.5 CME/CEU credits for a fee of$25 per CME/CEU certificate. Physicians and allied health professionals should only claim credit commensurate with the extent of their participation in the webinar activity. Nurses, pharmacists, social workers, and other allied health professionals may also claim CE credits.


Click here to register for CME/CEU.